Agilent Technologies Opens Global Manufacturing Facility for Life Sciences Instruments

03-11-2010: Agilent Technologies Inc. announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company’s Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.

“The opening of the LC/MS manufacturing facility marks a milestone in Agilent’s continued investment in Singapore, which began in 1970,” said Bill Sullivan, Agilent president and CEO. “Singapore is the ideal location for this facility as it will provide us with greater access to the life sciences instrument market in Asia. The new facility also will bring us closer to our customers, as the pharmaceutical and biopharmaceutical industries have become an important part of Singapore’s overall economy and investment strategy.”

The Agilent LC/MS facility is located within the Agilent Life Sciences Group Order Fulfillment Center, located at its Yishun, Singapore, site. The center will be responsible for efficient management of the supply-chain network -- including planning, procurement, value-added engineering and logistics. The center ensures that the LC/MS facility is able to efficiently and effectively deliver configurable solutions to customers worldwide while maintaining Agilent’s hallmark of quality.

More about Agilent
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE